A61K 39/42
Viral
Official title: viral
A61K39/42 (Viral) appears on 458 US grants and 747 published applications in this corpus.
Search patents in A61K- Granted patents
- 458
- Published applications
- 747
- Assignees
- 376
- Inventors
- 1,400
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 5 |
| 2004 | 1 | 3 |
| 2005 | 1 | 5 |
| 2006 | 2 | 6 |
| 2007 | 7 | 13 |
| 2008 | 1 | 7 |
| 2009 | 2 | 8 |
| 2010 | 4 | 9 |
| 2011 | 5 | 11 |
| 2012 | 12 | 29 |
| 2013 | 13 | 32 |
| 2014 | 13 | 35 |
| 2015 | 27 | 34 |
| 2016 | 27 | 55 |
| 2017 | 24 | 47 |
| 2018 | 32 | 51 |
| 2019 | 42 | 61 |
| 2020 | 39 | 62 |
| 2021 | 39 | 53 |
| 2022 | 32 | 57 |
| 2023 | 30 | 45 |
| 2024 | 38 | 56 |
| 2025 | 35 | 42 |
| 2026 | 11 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acid antibody constructs for use against Ebola virus4 Aug 2026US 12,697,386 B2The Wistar Institute of Anatomy and Biology
- Polyomavirus neutralizing antibodies16 Jun 2026US 12,653,885 B2Novartis AG
- Immunogenic trimers2 Jun 2026US 12,642,848 B2International AIDS Vaccine Initiative
- Nucleic acid antibody constructs for use against respiratory syncytial virus5 May 2026US 12,617,841 B2The Wistar Institute of Anatomy and Biology
- Tumor-targeting A56 protein or fragment thereof, antibody binding to A56 protein, and use thereof28 Apr 2026US 12,612,448 B2Bionoxx Inc.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Compositions and methods related to multivalent binders for antiviral therapeutics27 Aug 2026US 2026/0248913 A1Arizona Board of Regents on behalf of Arizona State University
- Recombinant hiv env polypeptides and their use27 Aug 2026US 2026/0250331 A1International AIDS Vaccine Initiative
- Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput cloning27 Aug 2026US 2026/0250643 A1Albert Einstein College of Medicine
- Parainfluenza virus 3 monoclonal antibodies20 Aug 2026US 2026/0240993 A1
Most cited
By later US patents
- Method for treating infectious respiratory diseases270US 5,290,540 AThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 1994
- System and method for measuring animals128US 8,036,429 B22011
- Zika virus RNA vaccines108US 10,124,055 B2ModernaTX, Inc. · 2018
- Monoclonal antibodies against hepatitis B virus82US 5,204,095 ANational Research Development Corporation · 1993
- Bacteria and immunoglobulin-containing composition for human gastrointestinal health67US 5,531,988 AMetagenics, Inc. · 1996